Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice

Cardiac damage is the major limiting factor for the clinical use of doxorubicin (DOX). Preclinical studies indicate that inflammatory effects may be involved in DOX-induced cardiotoxicity. N(ε)-(carboxymethyl) lysine (CML) is suggested to be generated subsequent to oxidative stress, including inflam...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Bruynzeel, A M E, Abou El Hassan, M A, Schalkwijk, C, Berkhof, J, Bast, A, Niessen, H W M, van der Vijgh, W J F
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2007
Assuntos:
Translational Therapeutics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360105/
https://ncbi.nlm.nih.gov/pubmed/17325706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603640
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares